Protective effect of metformin on gentamicin-induced vestibulotoxicity in rat primary cell culture

Clinical and Experimental Otorhinolaryngology

Volumn 7, Issue 4, 2014, Pages 286-294

  Lee, Ji Young ^a   Lee, Se Hee ^a   Chang, Ji Won ^a   Song, Jae June ^a   Jung, Hak Hyun ^a   Im, Gi Jung ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Calcium; Gentamicins; Labyrinth vestibule; Metformin; Reactive oxygen species

Indexed keywords

EID: 84911392333     PISSN: 19768710     EISSN: 20050720     Source Type: Journal    
DOI: 10.3342/ceo.2014.7.4.286     Document Type: Article

References (30)

1. Sajjadi H, Paparella MM. Meniere's disease. Lancet. 2008 Aug; 372(9636): 406-14.
2. Schuknecht HF. Ablation therapy in the management of Meniere's disease. Acta Otolaryngol Suppl. 1957; 132: 1-42.
3. Pullens B, van Benthem PP. Intratympanic gentamicin for Meniere's disease or syndrome. Cochrane Database Syst Rev. 2011 Mar; (3): CD008234.
4. Huon LK, Fang TY, Wang PC. Outcomes of intratympanic gentamicin injection to treat Meniere's disease. Otol Neurotol. 2012 Jul; 33(5): 706-14.
5. Blakley BW. Update on intratympanic gentamicin for Meniere's disease. Laryngoscope. 2000 Feb; 110(2): 236-40.
6. Minor LB. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. Am J Otol. 1999 Mar; 20(2): 209-19.
7. Pender DJ. Gentamicin tympanoclysis: effects on the vestibular secretory cells. Am J Otolaryngol. 1985 Sep-Oct; 6(5): 358-67.
8. Beck C. Intratympanic application of gentamicin for treatment of Meniere's disease. Keio J Med. 1986 Mar; 35(1): 36-41.
9. Tange RA, Conijn EA, van Zeijl LG, Huizing EH. Pattern of gentamicin-induced cochlear degeneration in the guinea pig: a morphological and electrophysiological study. Arch Otorhinolaryngol. 1982; 236(2): 173-84.
10. Quaranta A, Scaringi A, Aloidi A, Quaranta N, Salonna I. Intratympanic therapy for Meniere's disease: effect of administration of low concentration of gentamicin. Acta Otolaryngol. 2001 Apr; 121(3): 387-92.
11. Dehne N, Rauen U, de Groot H, Lautermann J. Involvement of the mitochondrial permeability transition in gentamicin ototoxicity. Hear Res. 2002 Jul; 169(1-2): 47-55.
12. Jacotot E, Costantini P, Laboureau E, Zamzami N, Susin SA, Kroemer G. Mitochondrial membrane permeabilization during the apoptotic process. Ann N Y Acad Sci. 1999; 887: 18-30.
13. Bernardi P, Scorrano L, Colonna R, Petronilli V, Di Lisa F. Mitochondria and cell death: mechanistic aspects and methodological issues. Eur J Biochem. 1999 Sep; 264(3): 687-701.
14. Brustovetsky N, Brustovetsky T, Purl KJ, Capano M, Crompton M, Dubinsky JM. Increased susceptibility of striatal mitochondria to calcium-induced permeability transition. J Neurosci. 2003 Jun; 23(12): 4858-67.
15. Bernardi P, Krauskopf A, Basso E, Petronilli V, Blachly-Dyson E, Di Lisa F, et al. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J. 2006 May; 273(10): 2077-99.
16. Fontaine E, Eriksson O, Ichas F, Bernardi P. Regulation of the permeability transition pore in skeletal muscle mitochondria: modulation by electron flow through the respiratory chain complex I. J Biol Chem. 1998 May; 273(20): 12662-8.
17. Hirose K, Westrum LE, Stone JS, Zirpel L, Rubel EW. Dynamic studies of ototoxicity in mature avian auditory epithelium. Ann N Y Acad Sci. 1999 Nov; 884: 389-409.
18. Ding D, Stracher A, Salvi RJ. Leupeptin protects cochlear and vestibular hair cells from gentamicin ototoxicity. Hear Res. 2002 Feb; 164(1-2): 115-26.
19. El-Mir MY, Detaille D, R-Villanueva G, Delgado-Esteban M, Guigas B, Attia S, et al. Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons. J Mol Neurosci. 2008; 34(1): 77-87.
20. Guigas B, Detaille D, Chauvin C, Batandier C, De Oliveira F, Fontaine E, et al. Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study. Biochem J. 2004 Sep; 382(Pt 3): 877-84.
21. Kukidome D, Nishikawa T, Sonoda K, Imoto K, Fujisawa K, Yano M, et al. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes. 2006 Jan; 55(1): 120-7.
22. Hou X, Song J, Li XN, Zhang L, Wang X, Chen L, et al. Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway. Biochem Biophys Res Commun. 2010 May; 396(2): 199-205.
23. Algire C, Moiseeva O, Deschenes-Simard X, Amrein L, Petruccelli L, Birman E, et al. Metformin reduces endogenous reactive oxygen species and associated DNA damage. Cancer Prev Res (Phila). 2012 Apr; 5(4): 536-43.
24. Im GJ, Chang JW, Choi J, Chae SW, Ko EJ, Jung HH. Protective effect of Korean red ginseng extract on cisplatin ototoxicity in HEI-OC1 auditory cells. Phytother Res. 2010 Apr; 24(4): 614-21.
25. Chang J, Jung HH, Yang JY, Choi J, Im GJ, Chae SW. Protective role of antidiabetic drug metformin against gentamicin induced apoptosis in auditory cell line. Hear Res. 2011 Dec; 282(1-2): 92-6.
26. Choi J, Im GJ, Chang J, Chae SW, Lee SH, Kwon SY, et al. Protective effects of apocynin on cisplatin-induced ototoxicity in an auditory cell line and in zebrafish. J Appl Toxicol. 2013 Feb; 33(2): 125-33.
27. Chang J, Yang JY, Choi J, Jung HH, Im GJ. Calcium imaging in gentamicin ototoxicity: increased intracellular calcium relates to oxidative stress and late apoptosis. Int J Pediatr Otorhinolaryngol. 2011 Dec; 75(12): 1616-22.
28. Orrenius S, McConkey DJ, Nicotera P. Role of calcium in toxic and programmed cell death. Adv Exp Med Bio. 1991; 283: 419-25.
29. Ouslimani N, Peynet J, Bonnefont-Rousselot D, Therond P, Legrand A, Beaudeux JL. Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells. Metabolism. 2005 Jun; 54(6): 829-34.
30. Bellin C, de Wiza DH, Wiernsperger NF, Rosen P. Generation of reactive oxygen species by endothelial and smooth muscle cells: influence of hyperglycemia and metformin. Horm Metab Res. 2006 Nov; 38(11): 732-9.